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Major malformations of the human eye, including microphthalmia and anophthalmia, are examples of phenotypes
that recur in families yet often show no clear Mendelian inheritance pattern. Defining loci by mapping is therefore
rarely feasible. Using a candidate-gene approach, we have identified heterozygous coding-region changes in the
homeobox gene OTX2 in eight families with ocular malformations. The expression pattern of OTX2 in human
embryos is consistent with the eye phenotypes observed in the patients, which range from bilateral anophthalmia
to retinal defects resembling Leber congenital amaurosis and pigmentary retinopathy. Magnetic resonance imaging
scans revealed defects of the optic nerve, optic chiasm, and, in some cases, brain. In two families, the mutations
appear to have occurred de novo in severely affected offspring, and, in two other families, the mutations have been
inherited from a gonosomal mosaic parent. Data from these four families support a simple model in which OTX2
heterozygous loss-of-function mutations cause ocular malformations. Four additional families display complex
inheritance patterns, suggesting that OTX2 mutations alone may not lead to consistent phenotypes. The high
incidence of mosaicism and the reduced penetrance have implications for genetic counseling.
Introduction
Abnormalities in the ocular development program can
lead to a variety of major structural defects of the eye
that present at birth (Graw 2003). At the severe end
of the spectrum are anophthalmia (absence of the eye
[MIM 206900]) and extreme microphthalmia (small eye
[MIM 309700]), which are likely to result from a variety
of developmental pathologies (Morrison et al. 2002).
Other common malformations include sclerocornea
(MIM 181700); anterior chamber malformations, in-
cluding aniridia (MIM 106210), colobomata (MIM
120200), and congenital cataracts (MIM 116700); and
disorders of early retinal differentiation. Diagnostically
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useful subclasses within these groups include optic-
fissure closure defects (colobomata affecting iris, optic
nerve, retina, and choroid) (Morrison et al. 2002), dis-
orders of early retinal differentiation (Leber congenital
amaurosis [LCA {MIM 204000}] and Walker-Warburg
syndrome [MIM 236670]) (Dobyns et al. 1989), and dis-
orders of lens induction or differentiation (congenital
cataract/aphakia [MIM 177075]) (Jamieson et al. 2002).
Each of these can be isolated or associated with microph-
thalmia and/or anophthalmia.
Ocular malformations display a broad range of in-
heritance patterns. Classic aniridia is almost always
caused by PAX6 (MIM 607108) haploinsufficiency and
is transmitted with high penetrance and expressivity
(Hanson 2003). In contrast, anophthalmia and severe
microphthalmia show some evidence of familial recur-
rence but usually no clear Mendelian transmission pat-
tern (Morrison et al. 2002). This is likely to be a re-
flection of several potentially interactive factors: oligo-
genic causation, gene-environment interactions, and
stochastic variation in development. There is increasing
recognition that, although non-Mendelian inheritance
Ragge et al.: OTX2 Mutations in Ocular Malformations 1009
patterns make gene identification more difficult, they
are ultimately very revealing about the complex molec-
ular networks that contribute to normal development
(Ming and Muenke 2002; van Heyningen and Yeyati
2004).
Several genes for anophthalmia, microphthalmia,
and coloboma (RAX [MIM 601881], CHX10 [MIM
142993], PAX6, MAF [MIM 177075], and SOX2
[MIM 184429]) have been identified by different meth-
ods, ranging from the candidate-gene approach to po-
sitional identification, often using informative chromo-
somal rearrangements (Azuma et al. 1999; Ferda-Percin
et al. 2000; Jamieson et al. 2002; Fantes et al. 2003;
Graw 2003; Voronina et al. 2004). Apart from SOX2,
which appears to account for ∼10% of severe anoph-
thalmias (Fantes et al. 2003; Ragge et al. 2005), none
of these can be considered a major causative gene, be-
cause each examined cohort revealed mutations in a
very small proportion of affected individuals. We de-
cided to search for additional causative mutations, using
a candidate-gene approach.
OTX2 (MIM 600037), a bicoid-type homeodomain
gene, is a vertebrate ortholog of the Drosophila gene
orthodenticle (Otd), which is required for anterior
brain, eye, and antenna formation (Finkelstein and Bon-
cinelli 1994) and for regulating the development of pho-
toreceptors and the expression of rhodopsin (Tahayato
et al. 2003). Mammals have three Otx genes: Otx1,
Otx2, and the more diverged Crx, which is known as
“Otx5” in lower vertebrates (Germot et al. 2001). All
three genes are expressed in the developing eye—Crx
almost exclusively so. Human CRX (MIM 602225) mu-
tations have been reported in retinal degenerations, in-
cluding cone-rod dystrophy (MIM 120970), late-onset
pigmentary retinopathy, and LCA (Freund et al. 1997;
Sohocki et al. 1998; Rivolta et al. 2001). Mouse Otx1
and Otx2 are expressed in developing neural and sen-
sory structures, including the brain, ear, nose, and eye
(Simeone et al. 1993; Martinez-Morales et al. 2001).
The spatiotemporally complex expression pattern is re-
flected in the large flanking region that is occupied by
enhancers required for the regulation of Otx2 expres-
sion (Kurokawa et al. 2004a, 2004b). Ectopic expres-
sion studies in Xenopus suggest that Otx2 operates
early, interacting with a network of eye-field transcrip-
tion factors, including Rx1, Pax6, and Six3 (Zuber et
al. 2003). During eye morphogenesis, initial expression
in the entire optic vesicle becomes restricted to the pre-
sumptive retinal pigment epithelium (RPE) (Simeone et
al. 1993; Bovolenta et al. 1997; Martinez-Morales et
al. 2001), where OTX2 protein interacts with the tran-
scription factor MITF (MIM 156845), leading to the
activation of target genes, including tyrosinase (Mar-
tinez-Morales et al. 2003). Later, OTX2 is increasingly
expressed in neural retinal cells, including postmitotic
neuroblasts (Bovolenta et al. 1997; Nishida et al. 2003).
Conditional ablation of Otx2 in neural retina leads to
loss of Crx expression and failure of photoreceptor de-
velopment (Nishida et al. 2003).
Homozygous Otx2-knockout embryos have gastru-
lation defects and die at midgestation with severe brain
anomalies (Acampora et al. 1995; Ang et al. 1996).
Heterozygotes show highly variable phenotypes—rang-
ing from acephaly; through micrognathia, anophthal-
mia, and microphthalmia; to normal—depending on
genetic background (Acampora et al. 1995; Matsuo et
al. 1995; Ang et al. 1996). Recurrent interstitial dele-
tions of human chromosome 14q22-q23 have been con-
sistently associated with anophthalmia (Brewer et al.
1998). No definitive analysis of OTX2 has been re-
ported in these cases, but the gene maps to the 14q22
genomic region and is a strong candidate for mutation
studies in anophthalmia and related eye anomalies.
We therefore undertook mutation analysis of the
OTX2 gene. The common 289-aa isoform is transcribed
from a 5-kb genomic region encompassing three ex-
ons. The protein has a homeodomain and a 192-aa
proline-, serine-, and threonine-rich C-terminal region,
which contains a highly conserved SIWSPA peptide se-
quence and a tandemly duplicated OTX tail, all motifs
shared with OTX1 (MIM 600036) and CRX (Germot
et al. 2001). Unrelated patients ( ) with a spec-np 333
trum of ocular malformations were assessed by direct
sequencing. Brain magnetic resonance imaging (MRI)
data were obtained for two affected individuals and for
an unaffected mutation carrier, and older diagnostic im-
ages from other patients were reassessed. The OTX2
expression pattern was studied in early human embryos
for comparison with the known mouse pattern.
Material and Methods
Patients and Controls
Patients with ocular malformation spectrum defects
( ) were recruited, with informed consent andnp 333
with appropriate ethics review committee approvals. De-
tailed case histories of individuals with OTX2 coding-
region sequence changes are available in appendix A
(online only). Control DNAs ( ) from apparentlynp 164
healthy adults were anonymized; they matched the pa-
tients in ethnicity (apart from patient 7, who was of
African origin [see the “Results” section]). We sequenced
94 DNAs in full, and a further 70 partially, over the
region of the proline missense mutations.
DNA Preparation
Genomic DNA was prepared from peripheral blood
by use of a Nucleon DNA extraction kit (Tepnel Life
Sciences). Buccal cell lysates were prepared from mouth-
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Table 1
PCR Primers for Amplification of the OTX2 Coding
Region
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
wash samples by resuspending the cell pellet in 100 ml
of 0.05 M NaOH, heating in a boiling water bath for
20 min, and then neutralizing with 12.5 ml of 1 M Tris
(pH 7.6).
PCR and Sequencing
The human OTX2 cDNA (GenBank accession num-
ber NM_172337) is encoded by three exons that are
located in BAC AL161757 (GenBank) at positions
59950–60217 (exon 1), 61214–6138 (exon 2), and
6322–64868 (exon 3). The cDNA numbering is derived
from the human OTX2 cDNA (GenBank accession
number NM_172337). We designed four genomic am-
plicons to cover the OTX2 coding region and some
flanking intronic sequences in each case: amplicon 1 con-
tained exon 1, amplicon 2 contained exon 2, and over-
lapping amplicons 3a and 3b covered the coding part
of exon 3. PCR primers are shown in table 1. PCRs were
performed in 96-well plates. For amplicons 1 and 2, 50
ng genomic DNA was amplified in a volume of 50 ml
containing 1# Qiagen HotStarTaq PCR buffer, 1.5 mM
MgSO4, 5 ml PCR enhancer buffer (Invitrogen), 0.2 mM
dNTPs, 250 nM forward primer, 250 nM reverse primer,
and 2 U of HotStarTaq polymerase. For amplicons 3a
and 3b, the PCR enhancer buffer was omitted and was
replaced with 10 ml of Q solution (Qiagen). Thermal
cycling was performed using an MJ PTC225 machine.
PCR conditions were 1 cycle of 95C for 15 min; 35
cycles of 94C for 30 s, 55C for 30 s, and 72C for 1
min; and 1 cycle of 72C for 5 min.
PCR products were run on a 2% agarose gel to ensure
adequate yield and to check for the absence of nonspe-
cific products. Unincorporated primers and dNTPs were
removed by incubating 5 ml of PCR product with 1 ml
of ExoSapIT (exonuclease I and shrimp alkaline phos-
phatase enzyme mix [USB]) for 45 min at 37C, followed
by 20 min at 80C to inactivate the enzyme.
Direct Sequencing
Sequencing of PCR products was performed in a 96-
well plate format, as described elsewhere (Aijaz et al.
2004), with the use of forward and reverse primers as
shown in table 1. Individual sequence traces were in-
spected using Chromas software (Technelysium). Mul-
tiple sequence traces were aligned and compared using
the phredPhrap program from the Consed package (see
the Laboratory of Phil Green Web site). All changes were
verified by performing a second PCR and sequencing
reaction on the patient’s DNA. Family members were
analyzed if samples were available.
RNA In Situ Hybridization
The expression pattern of OTX2 was investigated by
nonradioactive RNA in situ hybridization in human em-
bryos from Carnegie stages (CS) 14–22, which corre-
spond approximately to mouse Theiler stages 18–23
(E11.25–E15.25). Human embryos were obtained from
the Medical Research Council/Wellcome Trust Human
Developmental Biology Resource, with full ethical ap-
proval. Preparation of embryo sections and nonradioac-
tive RNA in situ hybridization was performed as de-
scribed elsewhere (Lai et al. 2003).
The template for the OTX2 probe was a 1.1-kb frag-
ment that was PCR amplified from exon 3 with the use
of primers hOTX2A (5′-GCG GAT CCA GTG CTC
CTG TGT CTA TCT GGA G-3′) and hOTX2D (5′-GCG
AAT TCC AGA GGT GGA GTT CAA GGT TGC-3′)
and that was cloned into pGEM-3Z. The construct was
linearized with BamHI and was transcribed with T7
RNA polymerase to synthesize the digoxygenin-labeled
antisense riboprobe.
MRI Analysis
MRI scanning was approved by the local institutional
ethics committees. All patients scanned for the present
study provided written informed consent. Patient 5 and
his unaffected mother underwent MRI scanning. MRI
acquisition parameters were TE p 4.2, TI p 450, TR
p 15, NEX p 1, flip angle p 20, acquisition matrix
256 # 128, and field of view 24 cm; 124 contiguous
slices were produced, with voxel dimension 0.9375 mm
# 0.9375 mm # 1.5 mm. An equivalent sequence was
used for patient 4B. These data were reformatted in mul-
tiple planes to allow careful examination of regions of
interest. Additionally, signal changes were inspected on
T2 and FastFLAIR sequences (T2 and PD sequence: TE1
p 30, TE2p 120, TRp 2000, NEXp 1, acquisition
matrix 256 # 128, field of view 24 cm # 18 cm, and
slice thickness 5 mm contiguous; FastFLAIR sequence:
TE1 p 152, TE2 p 2200, TR p 10002, NEX p 1,
acquisition matrix 256# 128, field of view 24 cm, and
slice thickness 5 mm contiguous). Patient 4B underwent
similar high-resolution T1-weighted MRI scanning. For
patients 1, 2, and 6, existing MRI data were reviewed.
For patient 3A, CT scan data were reviewed.
Psychometric Testing
Patient 5 and his mother underwent standard neu-
ropsychometric testing, omitting any tests requiring vi-
sual function. This component of the study was also
approved by the local institutional ethics committee and
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was undertaken after written informed consent was
obtained.
Results
OTX2 Mutation Analysis
Of the 333 patients analyzed, 8 showed sequence var-
iation in the OTX2 coding region. The changes are dis-
tributed throughout the ORF (fig. 1). Additional family
members were analyzed, if samples were available, for
a total of 11 affected individuals in eight families (fig.
1). Detailed case histories of affected individuals are pre-
sented in appendix A (online only), and the phenotypes
are summarized in table 2. In the course of the study,
we uncovered evidence of mosaicism; therefore, when
possible, we also analyzed oral epithelial DNA (obtained
by mouthwash or buccal scrape).
Patient 1, with bilateral anophthalmia, has a de novo
frameshifting insertion (c.635insGC) at codon 155 in
exon 3, the A in the SIWSPA motif (figs. 1 and 2 and
table 2). Subsequent out-of-frame translation of 22 ami-
no acids is predicted to terminate at a TGA codon, be-
ginning at c.701. Neither the parents nor the unaffected
brother carry the mutation (fig. 1). Identical results were
obtained with buccal cell DNA from all four individuals.
Patient 2, with bilateral optic-nerve aplasia (MIM
165550) and microphthalmia (fig. 3 and table 2), has a
de novo transversion, c.436CrG, in exon 3 (fig. 1). This
is predicted to produce an arginine-to-glycine (R89G)
change at position 52 of the homeodomain. Neither par-
ent carries the change in lymphocyte DNA (fig. 1).
Patient 3A, with severe bilateral microphthalmia,
has an N-terminal domain frameshifting mutation,
c.252delC, in codon 27 of exon 1 (figs. 1 and 2 and
table 2). Out-of-frame translation is predicted until the
first base of a termination codon is encountered at c.320
in exon 2. A fetus (patient 3B [fig. 1]), terminated after
ultrasound diagnosis of affected status, also carried the
same mutation. The phenotypically normal mother of
patients 3A and 3B was found to have the mutation at
low levels in blood and buccal DNA before the existence
of the affected fetus was revealed. The unaffected father
and maternal grandparents do not have the mutation in
blood DNA (fig. 1). These data indicate that the mother
is a gonosomal (gonadal and somatic) mosaic carrier of
the mutation (Edwards 1989).
Siblings 4A and 4B—diagnosed with microphthalmia
and severe developmental delay and with LCA, respec-
tively (figs. 2 and 4 and table 2)—carry a transversion,
c.708TrA, in exon 3 (fig. 1). The tyrosine-to-termina-
tion (TATrTAA) change at codon 179 is in the C-ter-
minal domain. Their mother (patient 4C) is a gonosomal
mosaic for the Y179X mutation (fig. 1). She has a later-
onset phenotype resembling pigmentary retinopathy (fig.
4).
Patient 5, with bilateral anophthalmia, has a frame-
shifting deletion, c.288delCC, in codons 39–40 in exon
2, at the start of the homeodomain (figs. 1 and 2 and
table 2). This mutation is predicted to generate a 46-aa
nonsense peptide before reaching a TAA termination co-
don, beginning at c.429 in exon 3. The phenotypically
normal mother of this patient has full representation of
the same mutation in both lymphocyte and buccal DNA,
indicating that she is probably a nonmosaic mutation
carrier. The unaffected father, brother, and sister do not
carry the mutation (fig. 1).
Patient 6, with bilateral anophthalmia, has the tran-
sition c.466CrT in exon 3 (figs. 1 and 2 and table 2).
Glutamine (CAA) is substituted by a termination codon
(TAA) at the second amino acid of the C-terminal do-
main (Q99X). The phenotypically normal father shows
full expression of the same mutation in his blood DNA,
suggesting that he is a constitutive mutation carrier. The
unaffected mother does not have the mutation (fig. 1).
Patient 7, with bilateral microphthalmia and left sclero-
cornea, has the transversion c.568CrA in exon 3 (figs.
1 and 2 and table 2). This results in replacement of
proline (CCC) with threonine (ACC) at position 133
(P133T). The patient’s phenotypically normal mother
and brother have the same change, but the patient’s un-
affected father and sister do not (fig. 1). Identical results
were obtained with DNA from blood and oral epithe-
lium from all five family members. P133 occurs at the
end of a highly conserved hexapeptide motif, SGQFTP,
in the C-terminal domain of vertebrate Otx2, Otx1, and
Crx proteins (Germot et al. 2001).
Patient 8, with unilateral anophthalmia, has the trans-
version c.571CrG in exon 3 (figs. 1 and 2 and table 2).
This replaces proline (CCC) with alanine (GCC) at
amino acid position 134 (P134A). The patient’s similarly
affected mother does not have this variant in blood or
oral epithelium. The father was not available for anal-
ysis. The patient’s unaffected maternal grandmother and
maternal great-grandmother do not have the change, nor
does a maternal half brother (fig. 1).
Ninety-four control individuals (188 chromosomes)
were examined by direct sequencing for the presence of
all the coding-region variants. An additional 70 individ-
uals were sequenced for the region containing prolines
133 and 134. None of the changes was observed in the
controls. Ethnic matching was not feasible for family 7,
who are of African origin, and therefore no conclusion
can be drawn about the frequency of this change in the
population from which patient 7 comes.
We detected three SNPs during the course of the pre-
sent study. All were located in noncoding regions: two
newly reported sites (submitted to NCBI dbSNP) in the
first intron, 26812 C/T (dbSNP accession number
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Figure 1 OTX2 mutation analysis in eight families with congenital eye malformations. Top, Schematic diagram of the human OTX2
cDNA, showing the homeodomain (“HD”) (red rectangle); SIWSPA motif (dark blue bar); SGQFTP motif (orange bar); and tandemly repeated
OTX-tail motif (dark blue triangles). NTDp N-terminal domain; CTDp C-terminal domain. Horizontal arrows show the extent of the three
exons. Vertical arrowheads show the position of each mutation, with the corresponding family number. Bottom, Pedigrees with representative
sequence traces. Genetic analysis was performed for all individuals except those with dashed outlines. Blackened symbolp affected; unblackened
symbol p unaffected; dashed outline p individual not available for analysis; blackened dot in unblackened symbol p unaffected mutation
carrier; unblackened dot in blackened symbol p affected individual without mutation; m p mosaic. Numbers to the left of each sequence
trace indicate generation and individual; patient numbers are also shown (in parentheses). In family 3, individuals II-1 and II-2 are second
cousins. For family 4, “N” is a normal control sequence for comparison. Arrowheads below the traces for individuals II-2 (family 3) and I-2
(family 4) indicate a low-level presence of the mutant allele.
ss35522250) and 269–70 C/A (dbSNP accession number
ss35522251), and one already-known variant near the
start of the 3′ UTR (c.1050 G/A) (dbSNP accession num-
ber rs171978).
MRI Data and Neuropsychometric Testing of OTX2
Mutation Carriers
Three of the patients with OTX2 mutations have se-
vere learning disabilities; these disabilities are associated,
in two patients, with frequent seizures (table 2). These
neurological phenotypes, together with the extensive ex-
pression of OTX2 in the brain, indicated that MRI scans
and neuropsychometric testing might be informative, as
shown for PAX6 (Sisodiya et al. 2001).
Patient 4B, patient 5, and the unaffected mother of
patient 5 had MRI scans. Patient 5 and his mother also
underwent neuropsychometric testing. Original diag-
nostic MRI data were reviewed for patients 1, 2, and 6,
and CT data were reviewed for patient 3A. For patients
2 and 3A, only ocular data were available.
In four of the six patients for whom data are available,
the optic nerves and optic chiasm are abnormal (fig. 3
and table 2). The nerves and chiasm are absent in
patients 2 and 6 and are hypoplastic in patient 5. In
patient 1, the optic nerve is absent on the anophthalmic
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Figure 2 Facial views of eight patients with OTX2 coding-region sequence changes: patient 1 (A), patient 3A (B), patient 4A (C), patient
4B (D), patient 5 (E), patient 6 (F), patient 7 (G), and patient 8 (H). Patients 5 and 7 are wearing prostheses in both eyes. Patient 8 is wearing
a prosthesis in the left eye.
side and is hypoplastic on the microphthalmic side; the
chiasm is thin.
Patients 3A and 5 both had slightly enlarged lateral
ventricles. A striking cerebral anomaly is evident in pa-
tient 6, who has bilateral abnormal hippocampal mor-
phology (fig. 5). A similar hippocampal malformation
was seen, on review, in patient 1.
Patient 5 functions intellectually just within the av-
erage ability range (Wechsler Adult Intelligence Scale–
Revised [WAIS-R]: verbal IQ [VIQ] 91). His verbal
memory was good and was in keeping with his intel-
lectual level (verbal learning and recall 25th–50th per-
centile). His performance on tests of executive skills was
average. His 55-year-old mutation-carrying mother has
no eye phenotype and functions intellectually at a level
comparable to that found for her son (VIQ 96). Her
memory was not as good as that of her son: after cor-
recting for age, her scores were in the 10th–25th per-
centile. Executive skills were average.
Patient 2 was described as having cognitive and lan-
guage skills at least age-appropriate for a blind child
when a neurodisability assessment was performed at age
4.5 years.
RNA In Situ Hybridization
The developing human eye at CS16–CS19, like that
of the mouse at a corresponding age, shows strong
OTX2 expression in the RPE layer and weaker OTX2
expression in the neural retina (fig. 6F, 6G, and 6H and
data not shown). Mice have low-level expression in the
E11 neural retina, which becomes restricted to the neu-
roblastic layer by E17.5 and which remains present in
the inner nuclear layer into the postnatal period (Mar-
tinez-Morales et al. 2001; Nishida et al. 2003).
OTX2 is widely expressed throughout the telenceph-
alon and mesencephalon at CS14, with a sharp cutoff
at the midbrain-hindbrain boundary (fig. 6A). OTX2
expression was observed in the lamina terminalis and
the floor of the telencephalon at CS16 (fig. 6B and 6C),
sites that have also been reported in mouse (Simeone et
al. 1993; Mallamaci et al. 1996; Simeone 2000). At
CS22, OTX2 was expressed in the choroid plexus, the
dorsal thalamus, and the roof of the mesencephalon (fig.
6E). In the developing nasal structures, OTX2 is seen
in the olfactory epithelium of the nasal pits at CS18 (fig.
6D), again mirroring the mouse patterns.
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Figure 3 Ocular findings for patient 2 at age 6 wk. The right eye (A) and left eye (B) are shown, both with persistent pupillary membrane
and tunica vasculosa lentis and a clear lens. Ultrasound scans of the right (C) and left (D) orbits show small eyes. In panel C, no optic nerve
is visible. In panel D, the thin cord extending posteriorly from the globe (arrowhead) may be the optic-nerve sheath. The left fundus (E) has
a white elevated area with a pigmented surrounding area and grayish tissue extending a short distance into the posterior segment. This may
be a hyaloid remnant. No retinal vessels are visible. The fundus is hypopigmented, with a granular appearance and a few choroidal vessels. F,
In electrophysiological tests, patient 2 (left) gave a small (!2 mV) but consistent response to flash “a” and “b” waves (control 110 mV). Visual
evoked potential (“VEP”) showed no consistent response to flash. Results from an age-matched control are shown (right).
Discussion
Using a candidate-gene approach, we found a wide spec-
trum of human phenotypes to be associated with OTX2
coding-region sequence changes. The phenotypes were,
however, significantly different from those in the mouse
knockouts (Acampora et al. 1995; Matsuo et al. 1995;
Ang et al. 1996). The inheritance patterns in the families
are diverse.
Spectrum of OTX2 Mutations and Genetic
Mechanisms
We found eight different heterozygous OTX2 exonic
changes in the patient cohort. Five of the eight changes
are predicted to cause premature protein truncation ei-
ther through direct creation of a stop codon or through
a frameshift (fig. 1 and table 2). The only mutation pre-
dicted to lead to haploinsufficiency through nonsense-
mediated decay (reviewed by Holbrook et al. [2004]) is
in family 3, in which a stop codon is predicted in exon
2. In the other four families (1, 4, 5, and 6), termination
is predicted in the last exon—making it likely that the
truncated protein is expressed and that it may function
in a dominant negative manner (Nussbaum et al. 2001).
The R89G de novo missense change found in patient
2 causes substitution of an invariant homeodomain ar-
ginine that is normally in contact with DNA phosphate
residues. Missense mutations of the homologous residue
have been identified in seven different homeodomain
proteins, three of them (PITX2 [MIM 601542], SIX3
[MIM 603714], and CRX) associated with eye disease
(Swaroop et al. 1999; D’Elia et al. 2001; Laflamme et
al. 2004).
The mutations found in patient 1 (635insGC) and
patient 2 (R89G) arose de novo. In siblings 3A and 3B
(252delC) and siblings 4A and 4B (Y179X), the se-
quence changes were inherited from mothers who were
found to carry, at a low level in blood DNA, the same
mutation as their offspring. In both cases, the mother
transmitted the mutation to two affected children, pro-
viding strong evidence that these mothers are gonosomal
mosaics with a high frequency of mutant cells in their
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Figure 4 Ocular findings in family 4. Patient 4B at age 28 years:
right fundus (A) and left fundus (B), both with pale optic disks,
atrophic maculae, and thin retinal vessels (arrowheads); right iris (C)
and left iris (D). The left iris has peripheral anterior synechiae (arrow).
Patient 4C (mosaic mother of patients 4A and 4B) at age 51 years:
right fundus (E) and left fundus (F), showing retinopathy with accu-
mulated pigment clumps (arrowheads).
germ lines (Edwards 1989). The parents of the mosaic
individual should not have the mutation, as observed in
family 3 (fig. 1). Gonosomal mosaic individuals may or
may not express clinical features themselves, depending
on the proportion and distribution of mutant cells in
their body. The mosaic mother in family 3 has undergone
a full eye examination, including high-resolution mul-
tifocal electroretinogram (ERG), and is ophthalmolog-
ically normal. The mosaic mother in family 4 (patient
4C) has progressive retinal dystrophy (fig. 4E and 4F),
with a self-reported history of undefined visual problems
from an early age. Typically, an affected mosaic indi-
vidual has a milder phenotype than his or her consti-
tutive offspring (Zlotogora 1998). This seems to be true
for patient 4C, since she has retinal pathology without
the structural eye defects observed in her children.
Families 1–4 fit a model in which OTX2 haploinsuf-
ficiency (loss of function in one allele) alone causes struc-
tural eye malformations. However, families 5 and 6 pro-
vide evidence of incomplete penetrance, since predicted
protein-truncating mutations identified in bilateral an-
ophthalmic children are also found in an unaffected
mother and father, respectively (fig. 1 and table 2).
Results from families 7 and 8 are difficult to interpret.
Both have missense substitutions at adjacent highly con-
served proline residues, but the functional consequences
of these sequence changes are unknown. Both families
show discordance of phenotype and genotype. For fam-
ily 7, no ethnically matched controls were available, so
the frequency of the P133T change in the population of
origin of family 7 is unknown. In family 8, the affected
son has the P134A change, but his very similarly affected
mother does not, making it highly unlikely that this se-
quence variant is a major contributor to the phenotype.
We shall now focus on the loss-of-function mutations.
Two different models, based on recent insights from
other human genetic diseases, may explain incomplete
penetrance. First, if OTX2 is the only locus involved,
the level of gene expression may be affected by stochastic
and/or genetic factors. This model assumes that an ab-
normal phenotype will be manifest if OTX2 expression
falls below a certain critical threshold level and if loss
of function of one copy reduces gene expression levels
close to this threshold. Stochastic fluctuations in tran-
scription levels, possibly influenced by environmental
factors but independent of genetic background, may re-
duce expression levels below the threshold. Evidence of
this comes from the observation that genetically identical
Otx2-knockout mice have highly variable phenotypes
(Matsuo et al. 1995). Genetic factors at the mutant lo-
cus—specifically, regulatory polymorphisms of the nor-
mal allele—can also determine penetrance by controlling
transcription levels (Gouya et al. 2002; Vithana et al.
2003). If the mutant allele is in trans to a strongly ex-
pressing normal allele, transcription is maintained above
the threshold, which explains the clinically unaffected
status of constitutive mutation carriers, but a weakly
expressing normal allele leads to expression below the
threshold required for normal development, and the ab-
normal phenotype is revealed (Gouya et al. 2002). The
human OTX2 locus spans 1500 kb and has numerous
distant enhancers that could be targets for regulatory
polymorphisms (Kurokawa et al. 2004b).
Second, digenic or oligogenic inheritance may mani-
fest as incomplete penetrance (Ming and Muenke 2002;
van Heyningen and Yeyati 2004). An example of digenic
inheritance is provided by a form of retinitis pigmentosa
in which affected individuals have heterozygous muta-
tions in both the ROM1 (MIM 180721) and RDS (MIM
179605) genes, which encode related components of an
oligomeric photoreceptor protein. Mutations at only one
locus do not lead to an abnormal phenotype; penetrance
is dependent on cosegregation of both mutations (Ka-
jiwara et al. 1994). Perhaps more relevant to the devel-
opmental complexity of the eye and brain is holopros-
encephaly (HPE [MIM 142945 and MIM 157170]), a
disease that frequently shows non-Mendelian segrega-
tion patterns (Ming and Muenke 2002). The complex
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Figure 5 Coronal MRIs from patient 5 (T1-weighted image [A]), a normal control (T1-weighted image [B]), and patient 6 (T2-weighted
image [C]). The left side of each image is the right side of the patient. In panels A and C, the hippocampi are circled. Panel B is labeled to
show the normal hippocampal and parahippocampal structures: 1 p body of the hippocampus; 2 p subiculum; 3 p ambient cistern; 4 p
parahippocampal gyrus; 5p collateral sulcus; 6p fusiform gyrus; 7p lateral occipitotemporal sulcus. The hippocampi and parahippocampal
structures are normal in panel A but are abnormal in panel C. Despite the different image parameters (T2 vs. T1 control), in panel C the
hippocampi are more vertically aligned and are more globular than ovoid. Instead of being tucked laterally into the temporal horns of the
lateral ventricles, the medial displacement and incomplete rotation of the hippocampi generate a cerebrospinal fluid–filled extension of the
temporal horns of the lateral ventricle (arrow).
inheritance patterns and range of phenotypes we observe
for OTX2 are similar to those reported for SHH (MIM
600725) and SIX3, the major contributors toward HPE
types 3 and 2, respectively (Nanni et al. 1999; Wallis et
al. 1999). Whereas some HPE-associated SHH and SIX3
mutations have arisen de novo, others have been inher-
ited from completely unaffected carrier parents (Nanni
et al. 1999; Wallis et al. 1999). The possibility that
interaction with modifier gene variants at other loci
may be required for full penetrance is supported by the
observation that, in three reported cases, affected indi-
viduals carry mutations in two HPE genes (SHH with
TGIF [MIM 602630] or ZIC2 [MIM 603073]) (Nanni
et al. 1999; Ming and Muenke 2002). Most HPE genes
are involved in developmental signaling, and it is pos-
sible that reduction in the dosage of one protein can be
buffered but two cannot, so that expression of an ab-
normal phenotype may depend on mutations in more
than one gene (Ming and Muenke 2002).
Of six families with loss-of-function mutations, four
have mutation-carrier parents (families 3, 4, 5, and 6
[fig. 1]), three of whom are unaffected. Two parents are
probably constitutive mutation carriers, and two are
gonosomal mosaics. This presents challenges for genetic
counseling of families with OTX2 mutations. Estimating
the risk of having an affected child is extremely difficult.
The relationship between levels of somatic and germline
mosaicism is unpredictable. Little is known about either
the precise stage at which the germ line is determined
in humans or the number of precursor cells recruited.
However, the number of cells ancestral to the germ line
in mammals is thought to be small, so an individual who
is gonosomal mosaic is likely to have a significant pro-
portion of germ cells carrying the mutation (Zlotogora
1998; Leuer et al. 2001). Consequently, a relatively high
recurrence risk is predicted for the offspring of gono-
somal mosaic individuals, even if the proportion of mu-
tant alleles in blood DNA is low. This has been observed
in practice by others (Zlotogora 1998; Leuer et al. 2001)
and in the present study, with both gonosomal mosaic
mothers passing the mutation to two affected offspring.
Constitutive-mutation-carrier parents are expected to be
at 50% risk of having an affected child; however, re-
currence was observed only in families with a mosaic
parent. The lack of penetrance of OTX2 mutations must
also be taken into account; the recurrence risk will pre-
sumably be lower if, as we suggest, other factors are
required for manifestation of an abnormal phenotype.
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Figure 6 Expression pattern of the human OTX2 gene in the developing head (A–E) and eye (F–H). Panels show representative results
of nonradioactive in situ hybridization with a human OTX2 probe. All panels (apart from panel C, which shows a sense control) show antisense
hybridization: CS14 sagittal (A); CS16 coronal (B and C); CS18 (D); CS22 sagittal (E); CS16 5# magnification of panel B (F); CS17 coronal
(G); CS19 transverse (H). Strong expression is seen in the RPE (panels B, D, F, G, and H), and weaker expression is seen in the neural retina.
Pigment formation has not yet begun at this stage; cp p choroid plexus; di p diencephalic vesicle; dt p dorsal thalamus; ey p eye; lp lens;
lt p lamina terminalis; me p medial eminence; mes p mesencephalic vesicle; mhb p midbrain/hindbrain boundary; mt p metencephalic
vesicle; myp myelencephalic vesicle; npp nasal pit; nrp neural retina; osp optic stalk; rhp rhombencephalic vesicle; rpep retinal pigment
epithelium; tel p telencephalic vesicle; vt p ventral thalamus.
The relevant factors are, however, already present in
families with one or more affected offspring.
Unaffected parents may be constitutive or mosaic
mutation carriers; therefore, it is essential to test them
for any OTX2 mutation identified in affected probands.
However, accurate estimates of the recurrence risk await
a molecular definition of the factors that determine pen-
etrance of these mutations.
Phenotypic Variability
OTX2 loss-of-function mutations are associated with
a broad spectrum of ocular phenotypes, ranging from
bilateral anophthalmia to mild microphthalmia with ret-
inal abnormalities. Asymmetry between the two sides,
also noted in other genetic ocular malformations (Fantes
et al. 2003; Ragge et al. 2005), is frequently seen. The
spectrum of neurological phenotypes is broad, ranging
from severe developmental delay to normal cognitive
development. Variable expressivity is illustrated by the
different phenotypes of siblings 4A and 4B.
The OTX2 transcription pattern in human embryos
is very similar to that described for mouse at the stages
examined. This is not always the case (Fougerousse et
al. 2000). The highly conserved expression pattern in-
dicates conserved transcriptional control mechanisms.
Analysis of the Otx2 loci in human, mouse, Xenopus,
zebrafish, and Fugu demonstrated that many of the dis-
tant enhancers that control Otx2 expression are func-
tionally conserved (Kurokawa et al. 2004a, 2004b).
These elements, spread over hundreds of kilobases of
genomic DNA, are possible targets for mutations/var-
iations that might influence phenotypic severity and
penetrance.
The ocular expression pattern of OTX2 correlates well
with the range of eye phenotypes observed in patients
with loss-of-function mutations. Otx2 interacts with Mitf
to specify the RPE, which is essential for normal eye de-
velopment (Martinez-Morales et al. 2003). Early RPE de-
fects cause gross structural abnormalities of the eye (Ray-
mond and Jackson 1995; Graw 2003). The anophthalmia
and severe microphthalmia phenotypes in our cohort may
result directly from loss of OTX2 function in the devel-
oping RPE.
In the developing neural retina, OTX2 regulates CRX,
and CRX mutations cause LCA and retinal degeneration
(Sohocki et al. 1998; Rivolta et al. 2001; Nishida et al.
2003). The retinal phenotypes in patients 4B (with an
original diagnosis of LCA) and 4C (resembling pigmen-
1020 Am. J. Hum. Genet. 76:1008–1022, 2005
tary retinopathy) may be due to disturbed OTX2 reg-
ulation of CRX function.
The optic nerve and chiasm were reduced or absent
in four of the six patients for whom MRI, CT, or ultra-
sound data were available (patients 1, 2, 5 and 6 [fig. 3
and table 2]). Optic-nerve aplasia, which is very rare, was
observed bilaterally in patients 2 and 6, with absence of
the chiasm, and unilaterally on the anophthalmic side in
patient 1, who also shows a thin chiasm. Hypoplasia of
optic nerves and chiasm was observed in patient 5. Al-
though OTX2/Otx2 is expressed in the optic stalk and
subsequently in the optic-nerve sheath, it is not expressed
in the optic nerve itself (fig. 6) (Simeone et al. 1993; Bo-
volenta et al. 1997; Martinez-Morales et al. 2001). Hy-
poplasia of the optic nerve and chiasm may therefore be
a secondary effect of abnormal retinal development. The
optic nerve is formed when retinal ganglion-cell axons
exit the globe. The majority of axons, encased in the optic
sheath, project to the contralateral side of the brain, form-
ing the optic chiasm in the ventral diencephalon (Rasband
et al. 2003). Otx2 is expressed in retinal ganglion cells
(Bovolenta et al. 1997), so OTX2 mutations may com-
promise the development of the optic nerve and the for-
mation of the chiasm.
Pronounced hippocampal malformation was observed
(fig. 5C) in patient 6, with bilateral anophthalmia, severe
developmental delay, and seizures beginning in infancy.
The hippocampus is derived from the alar plate, which
develops from an OTX2-expressing domain of the neu-
ral plate (Fernandez-Garre et al. 2002). Patient 4A was
the other individual in the cohort with severe develop-
mental delay and seizures with teenage onset (table 2).
Unfortunately, no MRI information is available for this
patient. However, a hippocampal abnormality similar to
that in patient 6 was observed in patient 1, a young child
with severe developmental and speech delay, like patient
4B, but currently without seizures. The association of
hippocampal malformation with seizures remains to be
confirmed as additional patients are identified.
It is interesting to note that the ocular defects reported
in heterozygous Otx2-knockout mice were usually ac-
companied by severe craniofacial malformations (Mat-
suo et al. 1995). Our data show that heterozygous OTX2
mutations in humans are associated with structural eye
malformations in the absence of gross craniofacial ab-
normalities. However, the phenotypic composition of our
study cohort leads to biased ascertainment of OTX2 mu-
tations in ocular malformation cases. A broader human
mutation study might reveal OTX2 mutations associated
with craniofacial malformation syndromes or seizure-as-
sociated brain defects in the absence of eye anomalies.
We have presented evidence that heterozygous loss-
of-function mutations in the OTX2 gene make a major
contribution to the genetic basis of anophthalmia and
microphthalmia in a small but significant proportion of
patients. Two notable findings of our study are the lack
of penetrance of OTX2 mutations and the high incidence
of gonosomal mosaicism. The factors that influence de
novo mutagenesis in the early embryo are unknown; it
is unclear at present whether some genes or genomic
regions are more susceptible than others following fer-
tilization or whether gonosomal mosaicism is more com-
mon than previously recognized and has simply been
underascertained. Of five nucleotide substitutions in our
cohort, four are transversions and one is a transition:
this unusual bias (Nachman and Crowell 2000) may hint
at novel mutational mechanisms. Elucidation of the fac-
tors that influence OTX2 penetrance is a high priority
and will assist with genetic counseling; in addition, fur-
ther studies will help to unravel the complex genetic
interactions that are responsible for the development of
the human eye.
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